BioCentury
ARTICLE | Company News

Oriel Therapeutics Inc., Novartis deal

April 26, 2010 7:00 AM UTC

Novartis' generics unit, Sandoz International GmbH, acquired Oriel for an undisclosed amount. Oriel develops generics for asthma and chronic obstructive pulmonary disease (COPD). Sandoz gains Oriel's ...